Product Images Dextrose

This is a description of a 5% Dextrose Injection in a 50mL container for intravenous use. The solution contains Dextrose monohydrate and water for injection and has a pH of 4.3. It is a single-dose product, and any unused portion should be discarded. The solution should not be used in blood transfusions due to possible Rouleau formation. Additives may be incompatible. It is advised to consult with a pharmacist before introducing any additives. The product should be stored at a controlled room temperature, protected from freezing. The overwrap acts as a moisture barrier. The solution is labeled as non-DEHP sterile. The expiration date and lot number are provided.*

This text contains details about a pharmaceutical product called 5% Dextrose Injection, USP. The package size is 50 mL x 60, and it should be stored at a temperature between 20° to 25°C (68° to 77°F) to protect it from freezing. The manufacturer is Fresenius Kabi located in Lake Zurich, IL 60047. Made in the USA. For more information, visit www.fresenius-kabi.com/us.*

This text describes a 5% Dextrose Injection, USP, in a 100 mL container for intravenous use. The solution contains Dextrose monohydrate and water for injection. It is a single-dose solution that should be discarded if unused. The product should be stored at 20° to 25°C and protected from freezing. Consult a pharmacist for compatibility with additives and use aseptic technique when preparing for use. The packaging is a moisture barrier, and the solution should be used immediately after removal.*

This is a description for a 5% Dextrose Injection, USP in a 100 mL container. It is manufactured by Fresenius Kabi in Lake Zurich, IL, USA. The product should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and protected from freezing. The National Drug Code (NDC) for this product is 65219-464-50 with the lot number and expiration date to be entered. For further details, visit www.fresenius-kabi.com/us.*

This text provides information about a 5% Dextrose Injection, USP solution in a 250 mL container for intravenous use. It contains 12.5 grams per 250 mL (50 mg per mL) and is only for single-dose use. The solution must be discarded if unused, and additives should be used cautiously to prevent Rouleau formation. The package insert should be consulted for the usual dosage. The solution should be used immediately after removing from the overwrap and stored at 20° to 25°C (68° to 77°F) to protect from freezing. The container closure is non-PVC, non-DEHP, sterile, and does not contain natural rubber latex.*

This is a label for a solution of 5% Dextrose Injection, USP in a 250 mL package. The product has an NDC code of 65219-458-30 and should be stored at 20° to 25°C (68° to 77°F) to prevent freezing. The manufacturer is Fresenius Kabi based in Lake Zurich, IL, and the product is made in the USA. The expiration date is also provided on the label.*

This text provides information on a 5% Dextrose Injection, USP solution with 25 grams per 500 mL. It is for intravenous use and should be discarded if unused. The solution contains dextrose monohydrate and water for injection. It cautions against using dextrose solutions without salts in blood transfusions. The solution must be used immediately after removal from the overwrap and stored at 20°C to 25°C. Consult a pharmacist for any incompatibility with additives. The container closure is non-PVC, non-DEHP, and latex-free.*

This text provides information about a 5% Dextrose Injection, USP in a 500 mL x 20 packaging. It includes details on storage conditions, lot number, expiration date, manufacturer (Fresenius Kabi), location (Lake Zurich, IL), and contact information. The product is made in the USA. The NDC number for the product is 65219-460-20 and there is a barcode number (01)50365219460201.*

This text appears to be a description of a 5% Dextrose Injection, USP solution in a 1,000 mL container for intravenous use. It includes information on the composition, osmolality, pH, proper usage, precautions, storage instructions, and manufacturing details. The solution should be used for single-dose only and any unused portion should be discarded. It is advised not to use this solution in blood transfusions due to possible Rouleau formation. Special care is required when introducing additives, ensuring aseptic technique and immediate use upon removal from the overwrap. The storage temperature recommendation is between 20°C to 25°C to prevent freezing. The container closure is latex-free and sterile. More specific dosage information is provided in the package insert.*

This text provides information about a product labeled with NDC 65219-462-10, which is 5% Dextrose Injection in a 1000 mL quantity packed in a case of 10. The storage conditions indicated are between 20° to 25°C (68° to 77°F) to prevent freezing. The manufacturer is Fresenius Kabi in Lake Zurich, IL 60047, and the product is made in the USA. The LOT and EXP numbers are not clear from this text.*